Bob McNally had a long and successful career in the medical biotech industry since graduating from Villanova and subsequently earning his PhD in Biomedical Engineering from the University of Pennsylvania. From his early career in cardiac pacing, he co-founded CryoLife, a Georgia-based human heart valve and tissue-for-transplant company, which went public on the New York Stock Exchange (CRY). As a serial entrepreneur he was involved in a number of startups, most recently as the now-retired President and CEO of GeoVax, a vaccine company newly listed on NASDAQ (GOVX).
Bob is a past chairman and recipient of the Georgia Biomedical Industry Growth Award from the Georgia affiliate of the Bio Innovation Organization (BIO). He’s a Fellow of the American Institute for Medical and Biological Engineers and a long time Georgia Tech advisory board member for Biomedical Engineering and the School of Business. At Villanova he is actively involved in the Innovation, Creativity and Entrepreneurship Institute and the Engineering Entrepreneurship advisory boards. For years, he has been passionate about encouraging a bioengineering degree at Villanova and fostering engineering entrepreneurial activity through interdisciplinary curricula to support engineers becoming successful CEOs.
Bob and his wife Gert reside on St Simons Island, Georgia.